---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-005126"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:01:28.292448+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bio-Path appoints Aline Sherwood to board, regains Nasdaq compliance

## Summary
- Aline Sherwood appointed to Bio-Path board effective March 31, 2022, filling vacancy left by Martina Molsbergen's Feb 14 resignation.
- Sherwood named to audit, compensation, nominating/corporate governance, and business development committees.
- Nasdaq notified company April 6, 2022 that board and audit committee now comply with listing rules 5605(b)(1) and 5605(c)(2)(A).
- Sherwood is principal of Scienta Communications; previously managed communications at The Liposome Company and WeissComm Group.

## SEC filing metadata
- accession: 0001558370-22-005126
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/bpth-20220331x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-005126
- JSON: https://secwatch.observer/filing/0001558370-22-005126.json
- Plain text: https://secwatch.observer/filing/0001558370-22-005126.txt

## Key facts
- Executive change
  Martina Molsbergen resigned as Director at BIO-PATH HOLDINGS, INC..
  - Action: resigned
  - Role: Director
  source text: On February 14, 2022, Martina Molsbergen resigned from her position as a member of the Board of Directors (the “Board”) of Bio-Path Holdings, Inc. (the “Company”) and all committees of the Board on which she served.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm
- Executive change
  Aline Sherwood was appointed as Director at BIO-PATH HOLDINGS, INC..
  - Action: appointed
  - Role: Director
  source text: On March 31, 2022, the Board appointed Aline Sherwood to the Board to fill the vacancy resulting from the resignation of Ms. Molsbergen.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.